DJIA 17,513.61 -169.97 -0.96%
NASDAQ 4,918.57 -73.38 -1.47%
S&P 500 2,051.80 -16.96 -0.82%
market minute promo

186.89 0.65 (0.35%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALXN $186.89 0.35%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $187.05
Previous Close $186.24
Daily Range $185.01 - $188.73
52-Week Range $150.06 - $203.30
Market Cap $37.3B
P/E Ratio 63.78
Dividend (Yield) $0.00 (0.0%)
Volume 439,403
Average Daily Volume 2,173,141
Current FY EPS $5.29

Sector

Healthcare

Industry

Drug Makers

Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website: http://www.alexionpharm.com/

News & Commentary

The Competitive Advantage of the Best Biotech Stocks

The 4-letter word that differentiates the best biotechs: M-O-A-T

US Stock Futures Drop Ahead Of Economic Data

Strensiq Receives Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia

Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress - Ana

Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress - Analyst Blog

10 Worst Health Care Stocks in the S&P 500

Andreas Halvorsen Increases Stake in Esperion Therapeutics

Alexion's Strensiq and Kanuma Get Positive CHMP Opinions - Analyst Blog

Is it Time for this Biotech to Change Management?

With Aegerion Pharmaceuticals down 500% from its all-time high, the current CEO's tenure is trying investors' patience.

Short Sellers Get More Selective on Big Biotech

Bernstein: Alexion Pharma An Outperform, Worth $267/Share

See More ALXN News...

ALXN's Top Competitors

ALXN $186.89 (0.35%)
Current stock: ALXN
AMGN $152.91 (-1.03%)
Current stock: AMGN
GILD $113.38 (-1.97%)
Current stock: GILD
BIIB $402.54 (-0.52%)
Current stock: BIIB